Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Blood Advances|September 28, 2020
Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patientsSlavica Vuckovic, Christian E Bryant, Ka Hei Aleks Lau, et al.
JAMA Neurology|March 31, 2025
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical TrialSteven J Warach, Lisa A Davis, Patrick Lawrence, et al.
Haematologica|January 21, 2018
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphomaZiduo Li, Xinsheng Ju, Kenneth Lee, et al.
Hemasphere|October 15, 2021
Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma AllianceStephen Boyle, Joshua W D Tobin, Jacinta Perram, et al.
JCO Precision Oncology|October 5, 2020
Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 TrialElisa Fontana, Gift Nyamundanda, David Cunningham, et al.
Lancet (London, England)|June 26, 2025
Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)Hakim-Moulay Dehbi, Urs Fischer, Signild Åsberg, et al.
Pageof 6